Private biotech market: Innovation, valuations, and capital efficiency

Co-heads of biotech private investments I-hung Shih and Nilesh Kumar join host Thomas Mucha to explore today's private biotech market, highlighting the state of deal flow, valuations, and innovation.

Key topics:

1:30 – The impact of scientific training on biotech investing

6:30 – The state of the private biotech market

9:30 – Groundbreaking innovations

12:15 – Secular trends in biotech investing

13:45 – Biotech’s valuation reset

16:15 – Regulation and drug pricing

19:15 – Wellington's broader health care perspectives

20:55 – The intersection of geopolitics and biotech innovation

23:30 – Collaborating with Wellington’s public health care team

26:15 – ESG and bioethics